Gibson Laboratories Recalls Blastomyces Antiserum Due to False Positives
Gibson Laboratories LLC is recalling Blastomyces dermatitidis Antiserum vials because the product was reporting false positive results.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II. The hazard involves false positive results in diagnostic testing, which is a quality issue without reported injuries or hospitalizations, fitting the criteria for a moderate severity recall.
Plain-English summary
Gibson Laboratories LLC is recalling 10 vials of Blastomyces dermatitidis Antiserum, 1 mL each, Catalog 200265. The product is intended for the identification of systemic fungal pathogens. The recall was initiated because the firm reported that the product was reporting false positive results.
The affected lot is # 5072543 with an expiration date of 03/12/2021. The Unique Device Identifier (UDI) is 10634853000039. The product was distributed to the states of Alabama, Arizona, and Mississippi.
Healthcare facilities and laboratories that have received this product should stop using it and contact the manufacturer for instructions on return or disposal. This recall is classified as Class II by the FDA.
The recalled product
- Product
- Blastomyces dermatitidis Antiserum 1 mL vial GIBSON BIOSCIENCE. Catalog 200265 Intended for identification of the systemic fungal pathogens.
- Manufacturer
- Gibson Laboratories LLC
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 5072543 Exp Date 03/12/2021
- UDI : 10634853000039.
Distribution
Related recalls
Same hazard · false positive
See all →- HighHealthmark ProChek-II Medical Tests Recalled for Expired Ingredient
FDA (Devices) · 2026-09-02
- HighAmyloid 1-42-N plasma calibrators recalled over falsely elevated results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma cartridges recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma calibrators recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighAmyloid 1-42-N plasma cartridges recalled over falsely elevated results
FDA (Devices) · 2026-02-11